Bio-Techne Corp Stock News

The stock market, as measured by the S&P 500 Index SPX, continued to move higher and deeper into overbought territory. A price was paid for that on December 20, when a small amount of selling turned i

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Puma Biotech (PBYI) or Techne (TECH). But which of these two stocks is more attractive to val

Bio-Techne's shares have fallen by a quarter since May, but the long-term thesis remains intact. The company has experienced low single-digit sales growth due to macro issues, but long-term potential

MINNEAPOLIS , Nov. 13, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: Stifel 2023 Healthcare Conference Novembe

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Puma Biotech (PBYI) and Techne (TECH). But which of these two stocks offers value investors a better bang for

Techne (TECH) came out with quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.45 per share a year ago.

You don't have to be a rocket scientist to know how important artificial intelligence ( AI ) is to the tech industry and the world in general. After all, I wouldn't be asked to write about AI stock sp

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Exelixis (EXEL) and Techne (TECH). But which of these two stocks offers value investors

Shockwave Medical just got a boost from a Medicare decision on one of its products. Bio-Techne is benefiting from increased cell and gene therapy revenue.

AFCG, AINC and TECH have been added to the Zacks Rank #5 (Strong Sell) List on October 3, 2023.

As of September 19, S&P 500 healthcare stocks were down 3.2% for the year. Of the 11 sectors, its year to date (YTD) performance is the second worst only behind utilities.

AVTR, TECH and CPRI have been added to the Zacks Rank #5 (Strong Sell) List on September 11, 2023.

AVTR, BHLB and TECH have been added to the Zacks Rank #5 (Strong Sell) List on August 22, 2023.

Although the revenue and EPS for Techne (TECH) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street es

Techne (TECH) came out with quarterly earnings of $0.55 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.51 per share a year ago.